| 892 | 13 | 326 |
| 下载次数 | 被引频次 | 阅读次数 |
乳腺癌位于全球发病率和致死率最高的恶性肿瘤前列，随着高精度诊疗数据越来越多，乳腺MRI影像组学表现出巨大潜力。本文总结了MRI影像组学在乳腺癌诊疗中的应用，简述了乳腺MRI影像组学的发展趋势及存在问题。认为MRI影像组学在乳腺癌诊断、疗效评估及淋巴结转移预测等中提供了丰富信息，促进了乳腺癌精准医疗的发展。虽然MRI影像组学在乳腺癌诊治的应用上还面临着很多挑战，但通过医工结合，乳腺MRI影像组学的乳腺癌研究势必会开拓出更大的发展空间，表现出更佳的临床应用前景。
Abstract：Breast cancer has become the most common malignancy with highest mortality in the world. It is believed that MRI radiomics based on big data technology can provide abundant information in breast cancer diagnosis, efficacy evaluation and lymph node metastasis prediction, and promote the development of precision medicine for breast cancer. Although there are still many challenges,breast MRI radiomics has great potential in clinical application.
[1]Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin,2021,71(3):209-249.
[2]江泽飞,许凤锐.乳腺癌精准治疗:20年探索历程.中国实用外科杂志, 2020,40(1):83-88.
[3]周星彤,沈松杰,孙强.中国乳腺癌筛查现状及进展.中国医学前沿杂志（电子版）, 2020,12(3):6-11.
[4]Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics:extracting more information from medical images using advanced feature analysis. Eur J Cancer, 2012,48(4):441-446.
[5]谢天文,彭卫军.乳腺影像组学.肿瘤影像学, 2021,30(5):321-326.
[6]Mann RM, Cho N, Moy L. Breast MRI:state of the art.Radiology, 2019,292(3):520-536.
[7]吴佩琪,杨雅俪,周妍璐,等.乳腺良恶性病变鉴别的MRI影像组学预测模型构建：基于随机森林、支持向量机、逻辑回归分类器.分子影像学杂志, 2021,44(5):764-770.
[8]杜小萌,陈艾琪,曹胜男,等.多参数MR影像组学标签鉴别非典型纤维腺瘤与浸润性乳腺癌.中国CT和MRI杂志,2022,20(5):130-133.
[9]张书海,王小雷,朱芸,等.多模态影像组学在鉴别乳腺良恶性病变中的应用研究.临床放射学杂志, 2021,40(11):2098-2104.
[10]Fusco R, Di Bernardo E, Piccirillo A, et al. Radiomic and artificial intelligence analysis with textural metrics extracted by contrast-enhanced mammography and dynamic contrast magnetic resonance imaging to detect breast malignant lesions. Curr Oncol, 2022,29(3):1947-1966.
[11]中国乳腺癌新辅助治疗专家组.中国乳腺癌新辅助治疗专家共识（2019年版）.中国癌症杂志, 2019,29(5):390-400.
[12]程凤燕,杨志企,廖玉婷,等.基于MRI影像组学模型与临床模型预测乳腺癌新辅助化疗病理完全缓解效能分析.国际医学放射学杂志, 2021,44(4):398-402.
[13]Chen XG, Chen XF, Yang JD, et al. Combining dynamic contrast-enhanced magnetic resonance imaging and apparent diffusion coefficient maps for a radiomics nomogram to predict pathological complete response to neoadjuvant chemotherapy in breast cancer patients. J Comput Assist Tomogr, 2020,44(2):275-283.
[14]Parikh J, Selmi M, Charles-Edwards G, et al. Changes in primary breast cancer heterogeneity may augment midtreatment MR imaging assessment of response to neoadjuvant chemotherapy. Radiology, 2014,272(1):100-112.
[15]Fan M, Chen H, You C, et al. Radiomics of tumor heterogeneity in longitudinal dynamic contrast-enhanced magnetic resonance imaging for predicting response to neoadjuvant chemotherapy in breast cancer. Front Mol Biosci, 2021,8:622219.
[16]Thibault G, Tudorica A, Afzal A, et al. DCE-MRI texture features for early prediction of breast cancer therapy response.Tomography, 2017,3(1):23-32.
[17]姚纯,杨志企,杨佳达,等.基于动态增强MRI影像组学评分和激素受体的列线图预测乳腺癌新辅助化疗不敏感的价值.国际医学放射学杂志, 2022,45(2):130-134.
[18]Xiong QQ, Zhou XZ, Liu ZY, et al. Multiparametric MRIbased radiomics analysis for prediction of breast cancers insensitive to neoadjuvant chemotherapy. Clin Transl Oncol,2020,22(1):50-59.
[19]朱娅娣,郁义星,杨玲.动态增强MRI影像组学模型术前预测乳腺癌前哨淋巴结转移.国际医学放射学杂志, 2021,44(6):632-637.
[20]徐敏,马宜传,张书海,等.基于双模态MRI影像组学术前预测浸润性乳腺癌腋窝淋巴结转移.蚌埠医学院学报,2021,46(12):1763-1767.
[21]夏旭东,段成洲,李铭,等.基于MRI影像组学列线图预测乳腺癌腋窝淋巴结转移.磁共振成像, 2022,13(1):118-122.
[22]Yu YF, Tan YJ, Xie CM, et al. Development and validation of a preoperative magnetic resonance imaging radiomics-based signature to predict axillary lymph node metastasis and diseasefree survival in patients with early-stage breast cancer. JAMA Netw Open, 2020,3(12):e2028086.
[23]周嘉音,尤超,顾雅佳.影像组学在乳腺癌的应用研究进展.国际医学放射学杂志, 2022,45(2):174-179.
[24]Li W, Yu K, Feng CL, et al. Molecular subtypes recognition of breast cancer in dynamic contrast-enhanced breast magnetic resonance imaging phenotypes from radiomics data. Comput Math Methods Med, 2019,2019:6978650.
[25]Zhu Z, Albadawy E, Saha A, et al. Deep learning for identifying radiogenomic associations in breast cancer. Comput Biol Med, 2019,109:85-90.
[26]陆欢,葛敏,王世威.动态增强MRI瘤内与瘤周影像组学特征对三阴性乳腺癌的诊断价值研究.浙江医学, 2021,43(15):1647-1651.
[27]Wang J, Kato F, Oyama-Manabe N, et al. Identifying triplenegative breast cancer using background parenchymal enhancement heterogeneity on dynamic contrast-enhanced MRI:a pilot radiomics study. PLoS One, 2015,10(11):e0143308.
[28]李薇,平学军,刘宇豪,等. MRI影像组学特征预测乳腺癌分子分型的价值.临床放射学杂志, 2021,40(9):1709-1714.
[29]刘晓东,王新宇,宁刚. MRI影像组学术前预测乳腺浸润性导管癌Ki-67表达.中国医学影像技术, 2022,38(2):210-214.
[30]Ma W, Ji Y, Qi L, et al. Breast cancer Ki67 expression prediction by DCE-MRI radiomics features. Clin Radiol, 2018,73(10):909.e1-909.e5.
[31]Sutton EJ, Oh JH, Dashevsky BZ, et al. Breast cancer subtype intertumor heterogeneity:MRI-based features predict results of a genomic assay. J Magn Reson Imaging, 2015,42(5):1398-1406.
[32]赵悠帆,陈中伟,周洁洁,等.基于DCE-MRI影像组学和临床特征的列线图在乳腺MRI BI-RADS 4类病灶中的诊断价值.温州医科大学学报, 2021,51(5):375-380.
[33]赵梦然.乳腺导管原位癌影像学表现和影像组学特征与其临床危险度相关性研究.天津:天津医科大学, 2020.
[34]余雅丽,蒋燕妮,王思奇,等. ADC图影像组学预测Luminal B型乳腺癌新辅助化疗疗效的初步研究.影像诊断与介入放射学, 2022,31(4):283-290.
[35]张丹丹,尤超,顾雅佳.基于动态增强MRI影像组学参数的观察者一致性研究.肿瘤影像学, 2021,30(4):252-256.
[36]李双双,侯震,刘娟,等.影像组学分析与建模工具综述.中国医学物理学杂志, 2018,35(9):1043-1049.
[37]Mazurowski MA, Zhang J, Grimm LJ, et al. Radiogenomic analysis of breast cancer:luminal B molecular subtype is associated with enhancement dynamics at MR imaging.Radiology, 2014,273(2):365-372.
[38]陈英,郑铖,易珍,等.肝脏及肿瘤图像分割方法综述.计算机应用研究, 2022,3(3):641-650.
[39]马明明,姜原,刘义,等. U-Net深度学习模型对DCE-MRI上乳腺肿块自动分割和定位的准确性分析.放射学实践,2020,35(8):1030-1036.
[40]Defeudis A, Mazzetti S, Panic J, et al. MRI-based radiomics to predict response in locally advanced rectal cancer:comparison of manual and automatic segmentation on external validation in a multicentre study. Eur Radiol Exp, 2022,6(1):19.
基本信息:
中图分类号:R737.9;R445.2
引用信息:
[1]张春灵,王宁,邴雪,等.MRI影像组学在乳腺癌诊疗中的应用进展[J].影像诊断与介入放射学,2022,31(05):377-381.